Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debbie Avant

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pediatric Blood & Cancer|January 22, 2013
The impact of the written request process on drug development in childhood cancerKristen M Snyder, Gregory Reaman, Debbie Avant, et al.
Journal of Clinical Pharmacology|April 25, 2015
Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modelingJian Wang, Andrea N Edginton, Debbie Avant, et al.
Pharmacoepidemiology and Drug Safety|December 22, 2015
Pediatric registries at the Food and Drug Administration: design aspects that increase their likelihood of successScott K Winiecki, M Isabel Tejero-Taldo, Debbie Avant, et al.
JAMA Pediatrics|November 20, 2018
Duration of Pediatric Clinical Trials Submitted to the US Food and Drug AdministrationKanecia O Zimmerman, P Brian Smith, Ann W McMahon, et al.
Pediatrics|July 16, 2014
Impact of pediatric exclusivity on drug labeling and demonstrations of efficacyGerold T Wharton, M Dianne Murphy, Debbie Avant, et al.
Therapeutic Innovation & Regulatory Science|August 15, 2017
Neonatal Safety Information Reported to the FDA During Drug Development StudiesDebbie Avant, Gerri Baer, Jason Moore, et al.
JAMA|September 14, 2006
Peer-reviewed publication of clinical trials completed for pediatric exclusivityDaniel K Benjamin, Philip Brian Smith, M Dianne Murphy, et al.
JAMA Pediatrics|December 11, 2013
Drug labeling and exposure in neonatesMatthew M Laughon, Debbie Avant, Nidhi Tripathi, et al.
Pediatric Nephrology (Berlin, Germany)|August 6, 2017
Effect of renal function on antihypertensive drug safety and efficacy in childrenKevin M Watt, Debbie Avant, Jennifer Sherwin, et al.
Archives of Pediatrics & Adolescent Medicine|December 10, 2009
Safety and transparency of pediatric drug trialsDaniel K Benjamin, P Brian Smith, M Jessica M Sun, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pediatric Blood & Cancer|January 22, 2013
The impact of the written request process on drug development in childhood cancerKristen M Snyder, Gregory Reaman, Debbie Avant, et al.
Journal of Clinical Pharmacology|April 25, 2015
Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modelingJian Wang, Andrea N Edginton, Debbie Avant, et al.
Pharmacoepidemiology and Drug Safety|December 22, 2015
Pediatric registries at the Food and Drug Administration: design aspects that increase their likelihood of successScott K Winiecki, M Isabel Tejero-Taldo, Debbie Avant, et al.
JAMA Pediatrics|November 20, 2018
Duration of Pediatric Clinical Trials Submitted to the US Food and Drug AdministrationKanecia O Zimmerman, P Brian Smith, Ann W McMahon, et al.
Pediatrics|July 16, 2014
Impact of pediatric exclusivity on drug labeling and demonstrations of efficacyGerold T Wharton, M Dianne Murphy, Debbie Avant, et al.
Therapeutic Innovation & Regulatory Science|August 15, 2017
Neonatal Safety Information Reported to the FDA During Drug Development StudiesDebbie Avant, Gerri Baer, Jason Moore, et al.
JAMA|September 14, 2006
Peer-reviewed publication of clinical trials completed for pediatric exclusivityDaniel K Benjamin, Philip Brian Smith, M Dianne Murphy, et al.
JAMA Pediatrics|December 11, 2013
Drug labeling and exposure in neonatesMatthew M Laughon, Debbie Avant, Nidhi Tripathi, et al.
Pediatric Nephrology (Berlin, Germany)|August 6, 2017
Effect of renal function on antihypertensive drug safety and efficacy in childrenKevin M Watt, Debbie Avant, Jennifer Sherwin, et al.
Archives of Pediatrics & Adolescent Medicine|December 10, 2009
Safety and transparency of pediatric drug trialsDaniel K Benjamin, P Brian Smith, M Jessica M Sun, et al.
Pageof 2